-
1 Comment
From a valuation standpoint, the stock is 98.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 22.8.
Based on the above factors, NeuroOne Medical Technologies Corporation gets an overall score of 1/5.
Industry | Medical Devices |
---|---|
ISIN | US64130M2098 |
Sector | Healthcare |
Exchange | NASDAQ |
CurrencyCode | USD |
Beta | 0.69 |
---|---|
PE Ratio | None |
Target Price | 3.15 |
Market Cap | 29M |
Dividend Yield | None |
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NMTC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025